Reduced growth of beard as the only diagnostic sign in a patient with macroprolactinoma.
Steinhoff
M
M
Rochlitz
H
H
Nussbaum
G
G
Georgieva
J
J
Zouboulis
C C
CC
D000236:Adenoma / Q000175:diagnosis / Q000188:drug therapy; D000328:Adult; D000077465:Cabergoline; D018491:Dopamine Agonists / Q000627:therapeutic use; D004873:Ergolines / Q000627:therapeutic use; D005145:Face; D006197:Hair / Q000254:growth & development*; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D008279:Magnetic Resonance Imaging; D008297:Male; D010911:Pituitary Neoplasms / Q000175:diagnosis / Q000188:drug therapy; D011388:Prolactin / Q000097:blood*; D013739:Testosterone / Q000627:therapeutic use; D013974:Thyroxine / Q000627:therapeutic use
D018491:Dopamine Agonists; D004873:Ergolines; D013739:Testosterone; D011388:Prolactin; D000077465:Cabergoline; D013974:Thyroxine; D006854:Hydrocortisone